InVivo Therapeutics Corp Preço/Valor Contábil
Qual é o Preço/Valor Contábil de InVivo Therapeutics Corp?
O Preço/Valor Contábil de InVivo Therapeutics Holdings Corp é 0.22
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em NASDAQ em comparação com InVivo Therapeutics Corp
O que InVivo Therapeutics Corp faz?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Empresas com preço/valor contábil semelhantes a InVivo Therapeutics Corp
- Sierra Metals tem Preço/Valor Contábil de 0.22
- Thor Mining Plc tem Preço/Valor Contábil de 0.22
- Amazon.com tem Preço/Valor Contábil de 0.22
- Voyager Digital tem Preço/Valor Contábil de 0.22
- Brand Architekts plc tem Preço/Valor Contábil de 0.22
- Planet Ventures tem Preço/Valor Contábil de 0.22
- InVivo Therapeutics Corp tem Preço/Valor Contábil de 0.22
- TTL Beteiligungs- und Grundbesitz-AG tem Preço/Valor Contábil de 0.22
- Hydoo International tem Preço/Valor Contábil de 0.22
- Tsakos Navigation tem Preço/Valor Contábil de 0.22
- China Communications Construction Co tem Preço/Valor Contábil de 0.22
- China Development Bank International Investment tem Preço/Valor Contábil de 0.22
- Integrated Waste Solutions tem Preço/Valor Contábil de 0.22